Electro-acupuncture (EA) in Children Undergoing Procedures for Congenital Heart Defects.
1 other identifier
interventional
59
1 country
1
Brief Summary
This is a single site, randomized, blinded, sham controlled, parallel group study to identify whether electro-acupuncture (EA) is a beneficial anesthesia adjunct in children undergoing procedures on their congenital heart defects (CHD).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 7, 2017
CompletedFirst Posted
Study publicly available on registry
September 29, 2017
CompletedStudy Start
First participant enrolled
November 15, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 14, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 14, 2024
CompletedAugust 21, 2024
August 1, 2024
6.8 years
August 7, 2017
August 19, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Troponin level
Troponin level Change from baseline. Troponin lab levels will be measured as a marker of myocardial injury. Children undergoing procedures for their congenital heart disease will have their troponin levels prior to the procedure and 6 hours after weaning from bypass. This study will look at differences between pre and post troponin values in the two groups.
baseline and 6 hours after weaning from cardiopulmonary bypass
Secondary Outcomes (2)
Evaluate the incidence and severity of pain in the post operative period
every 2 hours for 48 hours after arrival in Pediatric Intensive Care Unit (PICU)
Evaluate Acute Kidney Injury
baseline and 6,12,24, and 48 hours after weaning from Cardiopulmonary bypass
Study Arms (2)
electro-acupuncture (EA) intervention
ACTIVE COMPARATORMicro electrodes will be placed at PC 4 and 6 , LI 4 and ST36. subjects will receive electro-acupuncture (EA) (treatment) mixed frequency( continuous plus dense disperse) will be at 2Hz and 100 Hz the amplitude will be 1000 microA.
sham electro acupuncture
SHAM COMPARATORMicro electrodes will be placed at PC 4 and 6 , LI 4 and ST36. subjects Receive sham (control) will not have stimulation.
Interventions
stimulation of acupuncture points related to congenital heart surgery for comfort heart and renal health
Eligibility Criteria
You may qualify if:
- Patients 0-18 years of age undergoing procedures on their congenital heart defects where an aortic cross clamp will be placed.
- Additionally, patients with coarctation of the aorta for repair will be considered as a separate group and eligible for enrollment.
- Willing to provide written Assent/Consent in English.
You may not qualify if:
- Patients with skin lesions over more than 50% of EA sites.
- Patients in renal failure.
- Patients on chronic opioid therapy.
- Unwilling to provide written Assent/Consent in English.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
West Virginia University
Morgantown, West Virginia, 26506, United States
Related Publications (1)
Rosen DA, Unger K, Gustafson RA, Trieu C, Zeltzer LK, Lin YC. Electroacupuncture Addition to the Anesthesia Care of Pediatric Patients for Congenital Heart Surgery. J Cardiothorac Vasc Anesth. 2017 Aug;31(4):1497-1504. doi: 10.1053/j.jvca.2017.02.037. Epub 2017 Feb 8. No abstract available.
PMID: 28526209BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David A Rosen, MD
West Virginia University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 7, 2017
First Posted
September 29, 2017
Study Start
November 15, 2017
Primary Completion
August 14, 2024
Study Completion
August 14, 2024
Last Updated
August 21, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share